Abstract:Obesity has a pronounced effect on the immune response in systemic organs that results in not only insulin resistance but also altered immune responses to infectious diseases and malignant tumors. Obesity-associated microenvironmental changes alter transcriptional expression and metabolism in T cells, leading to alterations in T-cell differentiation, proliferation, function, and survival. Adipokines, cytokines, and lipids derived from obese visceral adipose tissue (VAT) may also contribute to the systemic T-cell phenotype, resulting in obesity-specific pathogenesis. VAT T cells, which have multiple roles in regulating homeostasis and energy utilization and defending against pathogens, are most susceptible to obesity. In particular, many studies have shown that CD4 T cells are deeply involved in the homeostasis of VAT endocrine and metabolic functions and in obesity-related chronic inflammation. In obesity, macrophages and adipocytes in VAT function as antigen-presenting cells and contribute to the obesity-specific CD4 T-cell response by inducing CD4 T-cell proliferation and differentiation into inflammatory effectors via interactions between major histocompatibility complex class II and T-cell receptors. When obesity persists, prolonged stimulation by leptin and circulating free fatty acids, repetitive antigen stimulation, activating stress responses, and hypoxia induce exhaustion of CD4 T cells in VAT. T-cell exhaustion is characterized by restricted effector function, persistent expression of inhibitory receptors, and a transcriptional state distinct from functional effector and memory T cells. Moreover, obesity causes thymic regression, which may result in homeostatic proliferation of obesity-specific T-cell subsets due to changes in T-cell metabolism and gene expression in VAT. In addition to causing T-cell exhaustion, obesity also accelerates cellular senescence of CD4 T cells. Senescent CD4 T cells secrete osteopontin, which causes further VAT inflammation. The obesity-associated transformation of CD4 T cells remains a negative legacy even after weight loss, causing treatment resistance of obesity-related conditions. This review discusses the marked transformation of CD4 T cells in VAT and systemic organs as a consequence of obesity-related microenvironmental changes.

Interferon-α-producing Plasmacytoid Dendritic Cells Drive the Loss of Adipose Tissue Regulatory T Cells During Obesity

Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity

Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice

Obese visceral adipose dendritic cells downregulate regulatory T cell development through IL-33

Deciphering visceral adipose tissue regulatory T cells: Key contributors to metabolic health

Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity

Adipose tissue regulatory T cells: differentiation and function

Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors

Obesity Reshapes Visceral Fat-Derived MHC I Associated-Immunopeptidomes and Generates Antigenic Peptides to Drive CD8+ T Cell Responses

Defective immunosuppressive function of Treg cells in visceral adipose tissue in MIF deficient mice

Adipocyte Adaptive Immunity Mediates Diet-Induced Adipose Inflammation and Insulin Resistance by Decreasing Adipose Treg Cells

Obesity accelerates T cell senescence in murine visceral adipose tissue

Increased Oxidative Stress and the Apoptosis of Regulatory T Cells in Obese Mice but Not Resistant Mice in Response to a High-Fat Diet.

Regulatory T cells differentiation in visceral adipose tissues contributes to insulin resistance by regulating JAZF-1/PPAR-γ pathway

Obesogenic Memory Maintains Adipose Tissue Inflammation and Insulin Resistance

Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential

Adipose-tissue Regulatory T Cells Are a Consortium of Subtypes That Evolves with Age and Diet.

Pleiotropic adipose Treg subsets, defined by Atf3 expression, modulate adipocyte energy expenditure and weight loss

Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance

Interleukin-27 signaling resists obesity by promoting the accumulation of Treg cells in visceral adipose tissue

Adipocyte subpopulations mediate lipolysis and obesity induced insulin resistance